These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21833048)

  • 61. Civic trust, scientific objectivity, and the publicity condition.
    Potter NN
    Am J Bioeth; 2010 Aug; 10(8):57-8. PubMed ID: 20694911
    [No Abstract]   [Full Text] [Related]  

  • 62. Testing medications in children.
    Steinbrook R
    N Engl J Med; 2002 Oct; 347(18):1462-70. PubMed ID: 12409558
    [No Abstract]   [Full Text] [Related]  

  • 63. Writing an application for a human subjects institutional review board.
    Colt HG; Mulnard RA
    Chest; 2006 Nov; 130(5):1605-7. PubMed ID: 17099043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human rights and ethical considerations in oral health research.
    Ellen RP; Singleton R
    J Can Dent Assoc; 2008 Jun; 74(5):439. PubMed ID: 18538067
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Imagination and attention: protecting participants in psychopharmacological research.
    Koski G
    Psychopharmacology (Berl); 2003 Dec; 171(1):56-7. PubMed ID: 14598015
    [No Abstract]   [Full Text] [Related]  

  • 66. A taxonomy of value in clinical research.
    Casarett DJ; Karlawish JH; Moreno JD
    IRB; 2002; 24(6):1-6. PubMed ID: 12683394
    [No Abstract]   [Full Text] [Related]  

  • 67. Response to open peer commentaries on "Social contexts influence ethical considerations of research".
    Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134
    [No Abstract]   [Full Text] [Related]  

  • 68. Making more sense of "minimal risk".
    Barnbaum D
    IRB; 2002; 24(3):10-3. PubMed ID: 12848183
    [No Abstract]   [Full Text] [Related]  

  • 69. [Independent ethics committees for clinical research in Argentina. An evaluation and a system to guarantee their independence].
    Gonorazky SE
    Medicina (B Aires); 2008; 68(2):113-9. PubMed ID: 18499958
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Letter to the editor: Would you know an undue inducement if you saw one?
    Schwab AP
    Am J Bioeth; 2005; 5(5):W17. PubMed ID: 16179291
    [No Abstract]   [Full Text] [Related]  

  • 71. IRBs, data sharing, and privacy of human subjects.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):3. PubMed ID: 12374179
    [No Abstract]   [Full Text] [Related]  

  • 72. [Pharmacogenetic studies: evaluation guidelines for research ethics committees. Scientific background and legal framework (I)].
    Rodríguez-Villanueva J; Alsar MJ; Avendaño C; Gómez-Piqueras C; García-Alonso F
    Med Clin (Barc); 2003 Jan; 120(2):63-7. PubMed ID: 12570916
    [No Abstract]   [Full Text] [Related]  

  • 73. NIH Policy on Single-IRB Review - A New Era in Multicenter Studies.
    Ervin AM; Taylor HA; Ehrhardt S
    N Engl J Med; 2016 Dec; 375(24):2315-2317. PubMed ID: 27974026
    [No Abstract]   [Full Text] [Related]  

  • 74. Inconsistent regulatory protection under the U.S. Common Rule.
    Evans BJ
    Camb Q Healthc Ethics; 2004; 13(4):366-79. PubMed ID: 15552328
    [No Abstract]   [Full Text] [Related]  

  • 75. RESEARCH ETHICS. Evidence gaps and ethical review of multicenter studies.
    Ervin AM; Taylor HA; Meinert CL; Ehrhardt S
    Science; 2015 Nov; 350(6261):632-3. PubMed ID: 26542556
    [No Abstract]   [Full Text] [Related]  

  • 76. Cancer trials and the Institutional Review Board (IRB).
    Kurtzman S; Lazzarini Z
    Cancer Treat Res; 2007; 132():11-30. PubMed ID: 17305015
    [No Abstract]   [Full Text] [Related]  

  • 77. Institutionalisation of Bulgarian ethics committees: history and current status.
    Krastev Y
    Indian J Med Ethics; 2011; 8(3):148-51. PubMed ID: 22106639
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 79. Review boards: vital to protect subjects.
    Gearhart C
    Nature; 2011 Sep; 477(7365):407. PubMed ID: 21938055
    [No Abstract]   [Full Text] [Related]  

  • 80. Review boards: all need closer scrutiny.
    Slack NC
    Nature; 2011 Sep; 477(7364):280. PubMed ID: 21921902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.